Israel removes cancer patients from third vaccine jab list | Inquirer News

Israel removes cancer patients from third vaccine jab list

/ 01:39 PM July 19, 2021

Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021. REUTERS/Dado Ruvic

 Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021. REUTERS FILE PHOTO

JERUSALEM — Israel on Sunday walked back part of its policy for third coronavirus vaccination shots, saying that contrary to a recent announcement, oncology patients should actually stick with two jabs only.

On Monday Israel began administering a third shot of the Pfizer/BioNTech inoculation to patients with compromised immune systems, including people who have had heart, lung and kidney transplants and some cancer patients.

Article continues after this advertisement

But on Sunday, the health ministry said that after reviewing data on hundreds of patients from oncology wards, “the recommendation at this stage is to not vaccinate” cancer patients.

FEATURED STORIES

“Nearly 90 percent of the patients receiving chemotherapy developed antibodies following the (two doses of) vaccination, and the level of antibodies remained high a number of months after the vaccination,” it said in a “clarification” to the health funds and hospitals administering the shots.

“In addition, the vaccination could have side effects… that could affect the oncological treatment,” the ministry said.

Article continues after this advertisement

Pfizer and BioNTech have said they would ask US and European authorities for permission to provide a third dose of their vaccine, but European regulators say it was too early to tell if a third was necessary.

Article continues after this advertisement

The World Health Organization has expressed concern that such a booster shot could come at the expense of countries whose citizens have not yet received their first two doses.

Article continues after this advertisement

Israel’s initial vaccine rollout of the Pfizer/BioNTech jab was among the world’s fastest, and helped to bring confirmed daily cases down to single digits last month.

It decided to go ahead with third shots in the light of evidence “that patients with immunosuppression do not develop an adequate antibody response after two doses” and after the number of daily cases began to rise.

Article continues after this advertisement

A spokesman for Sheba medical centre, Israel’s largest hospital, told AFP that “dozens” of cancer patients have received a third shot since Monday.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Health, Israel, third dose

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.